Article Versions Notes

Inoue T, Fu B, Nishio M, Tanaka M, Kato H, Tanaka M, Itoh M, Yamakage H, Ochi K, Ito A, et al. Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis. Nutrients. 2023; 15(2):350. https://doi.org/10.3390/nu15020350

Inoue, Takayuki, Bin Fu, Miwako Nishio, Miyako Tanaka, Hisashi Kato, Masashi Tanaka, Michiko Itoh, Hajime Yamakage, Kozue Ochi, Ayaka Ito, and et al. 2023. "Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis" Nutrients 15, no. 2: 350. https://doi.org/10.3390/nu15020350

Inoue, T., Fu, B., Nishio, M., Tanaka, M., Kato, H., Tanaka, M., Itoh, M., Yamakage, H., Ochi, K., Ito, A., Shiraki, Y., Saito, S., Ihara, M., Nishimura, H., Kawamoto, A., Inoue, S., Saeki, K., Enomoto, A., Suganami, T., & Satoh-Asahara, N. (2023). Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis. Nutrients, 15(2), 350. https://doi.org/10.3390/nu15020350